Drugs / LM-2417
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06682780 | Sep 2025 → Dec 2028 expected | neoplasm | LaNova Medicines Limited | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LM-2417 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06682780 ↗ |